Trial Investigates Focused Ultrasound For Parkinson's Disease Tremor
This article was originally published in The Gray Sheet
Executive Summary
Clinicians discuss a feasibility trial of InSightec's focused ultrasound technology to reduce tremor related to Parkinson’s disease and a registry to show the effectiveness of focused ultrasound in treating uterine fibroids.
You may also be interested in...
InSightec’s Focused Ultrasound Shows Early, Positive Data For Disabling Tremor
The results are an encouraging sign not only for the company but also for the novel device development model employed by the trial’s sponsor, the Focused Ultrasound Foundation.
InSightec Wins Funding, New Management From GE Healthcare
Newly appointed InSightec chairman is GE Healthcare Systems’ CEO Tom Gentile. Israeli firm’s new CEO is former GE exec Jim Davis.
New Products In Brief
InSightec, TriVascular and NicOx are among firms with notable recent product approvals or launches.